Global Respiratory Distress Syndrome Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Respiratory Distress Syndrome Market Overview

• 1.1 Product Overview and Scope of Respiratory Distress Syndrome
• 1.2 Classification of Respiratory Distress Syndrome by Types
  • 1.2.1 Global Respiratory Distress Syndrome Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Respiratory Distress Syndrome Revenue Market Share by Types in 2018
  • 1.2.3 Poractant Alfa
  • 1.2.4 Beractant
  • 1.2.5 Calfactant
  • 1.2.6 Others
• 1.3 Global Respiratory Distress Syndrome Market by Application
  • 1.3.1 Global Respiratory Distress Syndrome Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Very Preterm Infants
  • 1.3.3 Moderate to Late Preterm Infants
  • 1.3.4 Others
• 1.4 Global Respiratory Distress Syndrome Market by Regions
  • 1.4.1 Global Respiratory Distress Syndrome Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Respiratory Distress Syndrome Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Respiratory Distress Syndrome Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Respiratory Distress Syndrome Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Respiratory Distress Syndrome Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Respiratory Distress Syndrome Status and Prospect (2014-2024)
• 1.5 Global Market Size of Respiratory Distress Syndrome (2014-2024)

2 Company Profiles

• 2.1 Chiesi Farmaceutici
  • 2.1.1 Business Overview
  • 2.1.2 Respiratory Distress Syndrome Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Market Breakdown by Regions
  • 2.2.1 Business Overview
  • 2.2.2 Respiratory Distress Syndrome Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Market Breakdown by Regions Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 AbbVie
  • 2.3.1 Business Overview
  • 2.3.2 Respiratory Distress Syndrome Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 CR-Double Crane
  • 2.4.1 Business Overview
  • 2.4.2 Respiratory Distress Syndrome Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Noargen
  • 2.5.1 Business Overview
  • 2.5.2 Respiratory Distress Syndrome Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 ONY Biotech
  • 2.6.1 Business Overview
  • 2.6.2 Respiratory Distress Syndrome Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Europe
  • 2.7.1 Business Overview
  • 2.7.2 Respiratory Distress Syndrome Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Europe Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 JW Pharmaceuticals
  • 2.8.1 Business Overview
  • 2.8.2 Respiratory Distress Syndrome Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Yuhan Corporation
  • 2.9.1 Business Overview
  • 2.9.2 Respiratory Distress Syndrome Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 North America
  • 2.10.1 Business Overview
  • 2.10.2 Respiratory Distress Syndrome Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 North America Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 China
  • 2.11.1 Business Overview
  • 2.11.2 Respiratory Distress Syndrome Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 China Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Korea
  • 2.12.1 Business Overview
  • 2.12.2 Respiratory Distress Syndrome Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Korea Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 RoW
  • 2.13.1 Business Overview
  • 2.13.2 Respiratory Distress Syndrome Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 RoW Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)

3 Global Respiratory Distress Syndrome Market Competition, by Players

• 3.1 Global Respiratory Distress Syndrome Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Respiratory Distress Syndrome Players Market Share
  • 3.2.2 Top 10 Respiratory Distress Syndrome Players Market Share
• 3.3 Market Competition Trend

4 Global Respiratory Distress Syndrome Market Size by Regions

• 4.1 Global Respiratory Distress Syndrome Revenue and Market Share by Regions
• 4.2 North America Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 4.3 Europe Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 4.5 South America Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

5 North America Respiratory Distress Syndrome Revenue by Countries

• 5.1 North America Respiratory Distress Syndrome Revenue by Countries (2014-2019)
• 5.2 USA Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 5.3 Canada Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

6 Europe Respiratory Distress Syndrome Revenue by Countries

• 6.1 Europe Respiratory Distress Syndrome Revenue by Countries (2014-2019)
• 6.2 Germany Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 6.3 UK Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 6.4 France Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 6.5 Russia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 6.6 Italy Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Respiratory Distress Syndrome Revenue by Countries

• 7.1 Asia-Pacific Respiratory Distress Syndrome Revenue by Countries (2014-2019)
• 7.2 China Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 7.3 Japan Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 7.4 Korea Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 7.5 India Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

8 South America Respiratory Distress Syndrome Revenue by Countries

• 8.1 South America Respiratory Distress Syndrome Revenue by Countries (2014-2019)
• 8.2 Brazil Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Respiratory Distress Syndrome by Countries

• 9.1 Middle East and Africa Respiratory Distress Syndrome Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 9.3 UAE Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

10 Global Respiratory Distress Syndrome Market Segment by Type

• 10.1 Global Respiratory Distress Syndrome Revenue and Market Share by Type (2014-2019)
• 10.2 Global Respiratory Distress Syndrome Market Forecast by Type (2019-2024)
• 10.3 Poractant Alfa Revenue Growth Rate (2014-2024)
• 10.4 Beractant Revenue Growth Rate (2014-2024)
• 10.5 Calfactant Revenue Growth Rate (2014-2024)
• 10.6 Others Revenue Growth Rate (2014-2024)

11 Global Respiratory Distress Syndrome Market Segment by Application

• 11.1 Global Respiratory Distress Syndrome Revenue Market Share by Application (2014-2019)
• 11.2 Respiratory Distress Syndrome Market Forecast by Application (2019-2024)
• 11.3 Very Preterm Infants Revenue Growth (2014-2019)
• 11.4 Moderate to Late Preterm Infants Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global Respiratory Distress Syndrome Market Size Forecast (2019-2024)

• 12.1 Global Respiratory Distress Syndrome Market Size Forecast (2019-2024)
• 12.2 Global Respiratory Distress Syndrome Market Forecast by Regions (2019-2024)
• 12.3 North America Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
• 12.4 Europe Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
• 12.6 South America Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology